NEMAURA MEDICAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0542 USD | -4.39% |
|
-35.55% | -75.25% |
| Apr. 10 | Nemaura Medical Inc. Announces Board Changes | CI |
| Feb. 12 | Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Evolution of the average Target Price on Nemaura Medical Inc.
Price target over the last 5 years
History of analyst recommendation changes
085.AtohmBkjWsrkUNycQzAKy6WaKyt0D6ZTmmLW2iA8964.O5RWrWFEKZKsZZOvFV9Ygsb9eV4OVv8J0wSRl09mgvxHiEjydWIP85EIjQ~656b43c70bb983e4f4472be41375ae24
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0542
USD
Average target price
1.5
USD
Spread / Average Target
+2,667.53%
High Price Target
1.5
USD
Spread / Highest target
+2,667.53%
Low Price Target
1.5
USD
Spread / Lowest Target
+2,667.53%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Nemaura Medical Inc.
| HC Wainwright | |
| EF Hutton | |
| Ascendiant Capital |
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- NMRD Stock
- Consensus Nemaura Medical Inc.
